...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Use of Real-Time Quantitative PCR to Compare DNA Isolation Methods
【24h】

Use of Real-Time Quantitative PCR to Compare DNA Isolation Methods

机译:使用实时定量PCR比较DNA分离方法

获取原文
   

获取外文期刊封面封底 >>

       

摘要

PCR-based diagnostics of genomic DNA and DNA from viruses, microorganisms, or tumor cells are rapidly becoming routine practice in the clinical laboratory. DNA isolation is usually the first step toward detection. Because of expanding numbers of DNA isolation methods, the choice between methods is becoming increasingly difficult. Especially when a low amount of target DNA is present, when only a limited amount of clinical sample is available, or when PCR inhibitors are expected to be present, isolation efficiency, repeatability, and removal of PCR inhibitors by the isolation method become critical factors, seriously affecting the final outcome of the experiment.Recently, a real-time quantitative PCR system [ABI PrismTM 7700 Sequence Detection System, Perkin-Elmer Applied Biosystems (PE)] was developed. Quantification is automatically performed in the exponential phase of the PCR reaction, where there is a linear relationship between the log of input target DNA quantity and the number of PCR cycles to reach an arbitrary fluorescence threshold (1)(2).The objective of this study was to evaluate this PCR system for standardization of DNA isolation methods. Therefore, we added a known amount of marker DNA copies, close to the detection limit of the PCR, to plasma, which we chose because of recent developments in diagnostic molecular oncology (3)(4). After isolating the DNA with four different methods, we used the PCR system to determine isolation efficiency and repeatability of each method.Blood from five healthy donors was collected in 10-mL EDTA tubes. Plasma was pooled and stored at ?80 °C. A 12.8-kb plasmid containing a cDNA sequence construct of the bcr-abl gene translocation was used as marker DNA. The plasmid was linearized with a restriction enzyme, cleaned using a QIAquick column (QIAGEN), and quantified using GeneQuant II RNA/DNA calculator (Pharmacia). A 10-fold serial dilution of the marker DNA …
机译:基于PCR的病毒,微生物或肿瘤细胞中基因组DNA和DNA的诊断正迅速成为临床实验室的常规操作。 DNA分离通常是检测的第一步。由于DNA分离方法的数量不断增加,因此在方法之间进行选择变得越来越困难。尤其是当目标DNA含量低,仅有限数量的临床样品可用或预期存在PCR抑制剂时,分离效率,可重复性以及通过分离方法去除PCR抑制剂成为关键因素,最近,开发了一种实时定量PCR系统[ABI PrismTM 7700序列检测系统,Perkin-Elmer Applied Biosystems(PE)]。定量是在PCR反应的指数阶段自动进行的,输入目标DNA数量的对数与达到任意荧光阈值的PCR循环数之间存在线性关系(1)(2)。这项研究旨在评估该PCR系统用于DNA分离方法的标准化。因此,我们向血浆中添加了已知数量的标记DNA拷贝,接近PCR的检测极限,这是由于诊断分子肿瘤学的最新发展而选择的(3)(4)。用四种不同的方法分离DNA后,我们使用PCR系统确定每种方法的分离效率和可重复性。在10 mL EDTA管中收集来自五名健康供体的血液。合并血浆,并保存在?80°C下。将含有bcr-abl基因易位的cDNA序列构建体的12.8kb质粒用作标记DNA。用限制酶使质粒线性化,用QIAquick柱(QIAGEN)清洗,并用GeneQuant II RNA / DNA计算器(Pharmacia)定量。标记DNA的10倍系列稀释液…

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号